PharmCADD is a company designed to accelerate drug discovery meanwhile performing a design without building or maintaining the infrastructure associated with high-performance computational resources. The platform for both the design and discovery in the PharmCADD is composed of the state-of-the art technology: AI (Artificial intelligence), Molecular Dynamics (MD), Quantum Calculation (QC), and Network theory. AI, which is data-derived technology emerges as a new trend which could potentially be very revolutionary in our modern world. It enables customers to accelerate the search for a certain or specific drug candidate in the vast existence of chemical space. On the other hand, MD and quantum calculation, physics-based technology, enables the customers to characterize potential drug candidates more precisely. The effective combination of the data-derived and physics-based technologies leads to more accurate and speedier drug discovery.
| Website | http://www.pharmcadd.com |
| Employees | 16 (11 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research, Discovery Tools (Healthcare), Biotechnology |
| Keywords | Drug Discovery, Computational Drug Design, Accelerated Drug Development, Drug Development Platform, High Performance Computing, Pharmaceutical Research, Pharmaceutical Software, Hpc Solutions, In Silico Drug Design, Molecular Modeling, Structure Based Drug Design, On Demand Computing, Precision Medicine, Cheminformatics, Bioinformatics, Scientific Computing |
| Competitors | Dassault Systèmes, Elsevier, Schrödinger, Simulations Plus, Inc., Chemical Computing Group, OpenEye, Cadence Molecular Sciences, PyMOL, Biosym Technologies, GROMAC +37 more (view full list) |
Looking for a particular PharmCADD employee's phone or email?
Sibsankar Kundu is the Director Drug Design of PharmCADD.
11 people are employed at PharmCADD.